{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-125203","form_type":"8-K","ticker":"LQDA","cik":"0001819576","company_name":"Liquidia Corp","filed_at":"2023-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.667848+00:00","generated_at":"2026-06-07T14:20:27.367832+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Liquidia prices $25M public offering at $7.16/share; CEO invests $1M in concurrent private placement","bullets":["3,491,620 shares priced at $7.16 in underwritten public offering; gross proceeds ~$25M.","Funds to support YUTREPIA commercial development, clinical trials (WHO Group 3, pediatric), and L606 development.","CEO Roger Jeffs invests ~$1M in parallel private placement of 139,665 shares at same price.","BofA Securities sole book-runner, BTIG lead manager; expected close Dec 14, 2023.","Directors Johnson and Manning participate with $10M aggregate investment."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-125203","json":"https://secwatch.observer/filing/0001104659-23-125203.json","markdown":"https://secwatch.observer/filing/0001104659-23-125203.md","text":"https://secwatch.observer/filing/0001104659-23-125203.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819576/000110465923125203/0001104659-23-125203-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819576/000110465923125203/tm2332695d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T14:20:27.367832+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"86c64f3e28512e3d1a6ffc616bd8d46e3d8c4c65","claim":"Liquidia Corp entered into Underwriting Agreement with BofA Securities, Inc. valued at Sale of 3,491,620 shares of common stock at $7.16 per share, gross proceeds approximately $25 millio (effective 2023-12-12).","evidence_excerpt":"On December 12, 2023, Liquidia Corporation, a Delaware corporation (the “Company”), entered into an underwriting agreement (the “Underwriting Agreement”) with BofA Securities, Inc. (“ Representative ”), as representative of the several underwriters named therein (collectively, the “Underwriters”), in connection with a sale of 3,491,620 shares (the “Public Shares”) of the Company’s common stock, par value $0.001 per share ( the “Common Stock), pursuant to a registration statement on Form S-3 (File No. 333-251394), filed with the United States Securities and Exchange Commission (the “SEC”) on December 16, 2020, and which was declared effective by the SEC on December 23, 2020, and the prospectus contained therein, as may be supplemented by a prospectus supplement (the “Prospectus Supplement ”) to be filed with the SEC pursuant to Rule 424(b) under the Securities Act of 1933, as amended (the “Securities Act ”), in an underwritten registered public offering (the “Offering”) at an offering p","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819576/000110465923125203/0001104659-23-125203-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"BofA Securities, Inc."},{"label":"Value","value":"Sale of 3,491,620 shares of common stock at $7.16 per share, gross proceeds approximately $25 millio"},{"label":"Effective","value":"2023-12-12"}],"fact_type":"material_agreement"},{"claim_id":"ab4b7e78f905ffd575ac9e83a3c29cd433d9e24e","claim":"Liquidia Corp entered into Common Stock Purchase Agreement with Roger Jeffs valued at Private sale of 139,665 unregistered shares of common stock at $7.16 per share, aggregate investment (effective 2023-12-12).","evidence_excerpt":"Concurrently with the Offering referenced above, on December 12, 2023, the Company entered into a common stock purchase agreement (the “Purchase Agreement”) with Roger Jeffs, the Chief Executive Officer of the Company, in connection with the private sale of 139,665 unregistered shares (the “Private Shares” and together with the Public Shares, the “Shares”) of the Company’s Common Stock, in a private placement at a purchase price of $7.16 per share for an aggregate investment amount of approximately $1 million (the “Private Placement”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819576/000110465923125203/0001104659-23-125203-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Roger Jeffs"},{"label":"Value","value":"Private sale of 139,665 unregistered shares of common stock at $7.16 per share, aggregate investment"},{"label":"Effective","value":"2023-12-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}